[1] Sulforaphane further reduces inflammation by decreasing NF-kB[2], which is responsible for regulating the expression of certain proteins involved in the inflammatory response
Moreover, it has been found that mitochondrial functions and integrity can be affected by many of the risk factors of ASD, including toxins, immune activation, medicines, and metabolic disturbances [17]
GLP-1 medications have become a popular method of losing weight and controlling other conditions, such as diabetes
The new rule by the Biden administration seeks to broaden access
LY3437943 (Retatrutide): discovery to clinical proof of concept (triple GLP-1/GIP/glucagon agonist, preclinical mechanism) Nature Reviews Endocrinology (2024) Multi-receptor agonists for metabolic disease (mechanism of GLP-1/GIP/glucagon co-activation) Diabetes Care (2024) Incretin-based therapies: GLP-1, GIP, and glucagon receptor pharmacology (metabolic pathways, energy expenditure) NEJM (2023) Supplementary Material Jastreboff et al